World's Best Scientists 2026 revealed!
david i smith

david i smith

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 86 14302 13465 7230 6690 203 21513
Genetics 84 1376 1304 649 609 197 20112

david i smith publications per year

The chart shows the history of publications by david i smith between 1978 and 2020, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. david i smith published across 43 years, from 1978 to 2020, averaging 4.9 papers a year. Output peaked at 20 publications in 1998. 2 of the 209 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1978 to 2020. Vertical axis: number of publications, 0 to 20. Peak 20 publications in 1998. 1978: 1 publication 1979: 1 publication 1980: 0 publications 1981: 0 publications 1982: 0 publications 1983: 1 publication 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 2 publications 1990: 0 publications 1991: 2 publications 1992: 0 publications 1993: 1 publication 1994: 4 publications 1995: 4 publications 1996: 3 publications 1997: 7 publications 1998: 20 publications 1999: 10 publications 2000: 11 publications 2001: 9 publications 2002: 9 publications 2003: 14 publications 2004: 12 publications 2005: 10 publications 2006: 6 publications 2007: 10 publications 2008: 5 publications 2009: 12 publications 2010: 9 publications 2011: 11 publications 2012: 10 publications 2013: 3 publications 2014: 10 publications 2015: 3 publications 2016: 1 publication 2017: 5 publications 2018: 1 publication 2019: 1 publication 2020: 1 publication
1978 2020

209 publications in total across all disciplines

View publications per year as a table
david i smith: publications per year, 1978 to 2020
Year Publications
1978 1
1979 1
1980 0
1981 0
1982 0
1983 1
1984 0
1985 0
1986 0
1987 0
1988 0
1989 2
1990 0
1991 2
1992 0
1993 1
1994 4
1995 4
1996 3
1997 7
1998 20
1999 10
2000 11
2001 9
2002 9
2003 14
2004 12
2005 10
2006 6
2007 10
2008 5
2009 12
2010 9
2011 11
2012 10
2013 3
2014 10
2015 3
2016 1
2017 5
2018 1
2019 1
2020 1
Total 209
Download as CSV

david i smith publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where david i smith sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 67 bars. Horizontal axis: publications, 45–54 to 703+. Vertical axis: number of scientists, 0 to 217. Most scientists, 217, have 125–134 publications. The last bar groups every scientist with 703 publications or more. The highlighted bar, 195–204 publications, is where this scientist sits. 45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45–54 publications 703+

This scientist: 197 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

View publications distribution as a table
Number of Genetics scientists by publication count, Research.com 2026 ranking edition. Based on 4,342 ranked scientists.
Publications Scientists This scientist
45–54 6
55–64 10
65–74 35
75–84 84
85–94 102
95–104 151
105–114 175
115–124 203
125–134 217
135–144 205
145–154 193
155–164 188
165–174 170
175–184 178
185–194 164
195–204 173 197
205–214 159
215–224 134
225–234 143
235–244 105
245–254 114
255–264 92
265–274 88
275–284 87
285–294 80
295–304 62
305–314 75
315–324 67
325–334 60
335–344 52
345–354 40
355–364 48
365–374 47
375–384 46
385–394 31
395–404 27
405–414 40
415–424 30
425–434 43
435–444 29
445–454 14
455–464 28
465–474 21
475–484 21
485–494 22
495–504 17
505–514 12
515–524 11
525–534 8
535–544 8
545–554 14
555–564 4
565–574 11
575–584 5
585–594 11
595–604 12
605–614 7
615–624 6
625–634 10
635–644 9
645–654 10
655–664 6
665–674 6
675–684 6
685–694 4
695–702 6
703+ 100
Download as CSV

david i smith D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where david i smith sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 61 bars. Horizontal axis: D-Index, 40–41 to 160+. Vertical axis: number of scientists, 0 to 191. Most scientists, 191, have 62–63 D-Index. The last bar groups every scientist with 160 D-Index or more. The highlighted bar, 84–85 D-Index, is where this scientist sits. 40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40–41 D-Index 160+

This scientist: 84 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

View D-Index distribution as a table
Number of Genetics scientists by D-index, Research.com 2026 ranking edition. Based on 4,342 ranked scientists.
D-Index Scientists This scientist
40–41 24
42–43 52
44–45 84
46–47 112
48–49 118
50–51 141
52–53 143
54–55 145
56–57 179
58–59 162
60–61 175
62–63 191
64–65 172
66–67 184
68–69 164
70–71 158
72–73 150
74–75 136
76–77 127
78–79 127
80–81 111
82–83 110
84–85 110 84
86–87 84
88–89 102
90–91 66
92–93 72
94–95 70
96–97 54
98–99 60
100–101 49
102–103 55
104–105 45
106–107 42
108–109 28
110–111 39
112–113 25
114–115 31
116–117 29
118–119 34
120–121 29
122–123 29
124–125 18
126–127 27
128–129 22
130–131 16
132–133 11
134–135 17
136–137 12
138–139 21
140–141 4
142–143 9
144–145 14
146–147 6
148–149 10
150–151 7
152–153 9
154–155 8
156–157 8
158–159 9
160+ 96
Download as CSV

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Cancer

His primary scientific interests are in Cancer research, Genetics, Chromosomal fragile site, Carcinogenesis and Gene. His studies deal with areas such as Mutation, Transfection, Lymphoma, Tumor suppressor gene and Virus Integration as well as Cancer research. His studies in Tumor suppressor gene integrate themes in fields like Lung cancer, AXIN2, Colorectal cancer and Exon.

His Chromosomal fragile site research includes themes of Fluorescence in situ hybridization, Aphidicolin, Cervical cancer and Genome instability. His work deals with themes such as Molecular biology and Virology, which intersect with Carcinogenesis. The study incorporates disciplines such as Bladder cancer and Urinary bladder in addition to Molecular biology.

His most cited work include:

  • Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. (431 citations)
  • Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss (270 citations)
  • A role for common fragile site induction in amplification of human oncogenes. (251 citations)

What are the main themes of his work throughout his whole career to date?

David I. Smith spends much of his time researching Genetics, Cancer research, Gene, Chromosomal fragile site and Molecular biology. His Cancer research research includes elements of Carcinogenesis, Cancer, Tumor suppressor gene, Cell and Mutation. His Cancer research is multidisciplinary, relying on both Carcinoma, Pathology and Oncology.

His Chromosomal fragile site study also includes fields such as

  • FHIT which intersects with area such as WWOX,
  • Fluorescence in situ hybridization which intersects with area such as Bacterial artificial chromosome. He interconnects Translocation Breakpoint, Messenger RNA and Gene mapping in the investigation of issues within Molecular biology. His study looks at the relationship between Loss of heterozygosity and topics such as Ovarian cancer, which overlap with Ovary.

He most often published in these fields:

  • Genetics (40.96%)
  • Cancer research (40.43%)
  • Gene (36.17%)

What were the highlights of his more recent work (between 2009-2020)?

  • Genetics (40.96%)
  • Cancer research (40.43%)
  • Gene (36.17%)

In recent papers he was focusing on the following fields of study:

His main research concerns Genetics, Cancer research, Gene, Cancer and DNA sequencing. His studies deal with areas such as Cell, Gene expression profiling, Transcriptome, microRNA and Lymphoma as well as Cancer research. His study on Chromosomal fragile site, RNA, Sequence analysis and Fusion gene is often connected to TP63 as part of broader study in Gene.

His Cancer study integrates concerns from other disciplines, such as Oncology and Untranslated region. His studies in DNA sequencing integrate themes in fields like Genome, Human genome, Genomics and Computational biology. His Human genome research is multidisciplinary, incorporating elements of Cervical cancer, Whole genome sequencing and Molecular biology.

Between 2009 and 2020, his most popular works were:

  • Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss (270 citations)
  • Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. (198 citations)
  • Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas (145 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Cancer

David I. Smith mainly investigates Genetics, Gene, Cancer research, Chromosomal fragile site and Exome sequencing. His research combines Cervical adenocarcinoma and Gene. David I. Smith combines subjects such as Gene expression profiling, Cervical cancer, Lymphoma, Pathology and microRNA with his study of Cancer research.

He works on Chromosomal fragile site which deals in particular with Chromosome Fragile Site. David I. Smith has included themes like Hereditary sensory and autonomic neuropathy, Cell cycle phase, DNA mismatch repair and Hereditary motor and sensory neuropathy in his Exome sequencing study. The concepts of his RNA study are interwoven with issues in Molecular biology and Gene knockdown.

Best Publications

  • Role for the p53 homologue p73 in E2F-1-induced apoptosis

    Meredith Irwin;Maria Carmen Marin;Andrew C. Phillips;Ratnam S. Seelan

  • Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

    Liu W;Dong X;Mai M;Seelan Rs

  • Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

    Haojie Huang;Kevin M. Regan;Fang Wang;Diping Wang

  • Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

    Ken Taniguchi;Lewis R Roberts;Ileana N Aderca;Xiangyang Dong

  • Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

    Karen H. Lu;Andrea P. Patterson;Lin Wang;Rebecca T. Marquez

  • Malignant pheochromocytoma: Current status and initiatives for future progress

    Graeme Eisenhofer;Stefan R. Bornstein;Frederieke M. Brouwers;Nai Kong V. Cheung

  • MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons

    Penka S. Petrova;Andrei Raibekas;Jonathan Pevsner;Noel Vigo

  • Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss

    Christopher J. Klein;Maria Victoria Botuyan;Yanhong Wu;Christopher J. Ward

  • Mutations in CHEK2 associated with prostate cancer risk.

    Xiangyang Dong;Liang Wang;Ken Taniguchi;Xianshu Wang

  • Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations

    Wanguo Liu;David I. Smith;Keri J. Rechtzigel;Stephen N. Thibodeau

  • Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.

    Horacio Murillo;Haojie Huang;Lucy J. Schmidt;David I. Smith

  • Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

    Rebecca T. Marquez;Keith A. Baggerly;Andrea P. Patterson;Jinsong Liu

  • A role for common fragile site induction in amplification of human oncogenes.

    Asaf Hellman;Eitan Zlotorynski;Stephen W Scherer;Joseph Cheung

  • Common fragile sites are preferential targets for HPV16 integrations in cervical tumors

    Erik C Thorland;Shannon L Myers;Bobbie S Gostout;David I Smith

  • Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

    Andrew L. Feldman;Ahmet Dogan;David I. Smith;Mark E. Law

  • Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.

    M J Ferber;D P Montoya;C Yu;I Aderca

  • Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.

    Jinping Lai;Jeremy Chien;Julie K. Staub;Rajeswari Avula

  • Genetic Analysis of Early- versus Late-Stage Ovarian Tumors

    Viji Shridhar;Ajay Pandita;Rajeswari Avula;Julie Staub

  • Long, abundantly expressed non-coding transcripts are altered in cancer

    Damon S. Perez;Tiffany R. Hoage;Jay R. Pritchett;Allison L. Ducharme-Smith

  • Replication of a Common Fragile Site, FRA3B, Occurs Late in S Phase and is Delayed Further Upon Induction: Implications for the Mechanism of Fragile Site Induction

    Michelle M. Le Beau;Feyruz V. Rassool;Mary E. Neilly;Rafael Espinosa

Frequent Co-Authors

Lewis R. Roberts
Lewis R. Roberts Mayo Clinic
Lynn C. Hartmann
Lynn C. Hartmann Mayo Clinic
Kerry D. Olsen
Kerry D. Olsen Mayo Clinic
Haojie Huang
Haojie Huang Mayo Clinic
Jeremy Chien
Jeremy Chien University of California, Davis
Bruce W. Eckloff
Bruce W. Eckloff Mayo Clinic
Yan W. Asmann
Yan W. Asmann Mayo Clinic
George Vasmatzis
George Vasmatzis Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics can open doors to a variety of healthcare and research careers. Many students interested in genetics also pursue nursing and advanced clinical roles, and online degrees are making this progression more accessible than ever.

Aspiring nurse practitioners can benefit from online nurse practitioner programs that offer flexibility and affordability. Those aiming to accelerate their careers may consider cheapest accelerated nursing programs, which save both time and cost while providing high-quality education.

Advancing even further, there are specialized options like online dnp fnp programs for those interested in clinical leadership or advanced practice. Additionally, registered nurses can expand their qualifications through online rn to bsn programs, bridging the gap to baccalaureate credentials and opening more career opportunities in genetics, education, and research.

Exploring these online degree options allows students to tailor their career pathway in genetics and healthcare, matching educational goals with the evolving demands of the field.

Best Scientists Citing david i smith

Trending Scientists

Recently Published Articles